CompletedNCT00773409

Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)

Studying Nephrogenic systemic fibrosis

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bracco Diagnostics, Inc
Principal Investigator: Gianpaolo Pirovano, MD
Bracco Diagnostics, Inc
Enrollment: 405 enrolled
Eligibility: All sexes
Timeline: 2008 – 2012

Study locations (1)

Bracco Diagnostics Inc., Princeton, New Jersey, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00773409 on ClinicalTrials.gov

← Back to all trials